They should treat each component as a governed asset with ownership, approval history, version tracking, and retirement criteria. That means tying the SBOM to release management, vulnerability response, and compliance records so the organisation can show what it shipped, what changed, and who accepted the risk at each stage.
Why This Matters for Security Teams
Medical device software rarely stays static, and open source components often become part of the regulated product rather than a disposable build convenience. Governance has to cover design, integration, verification, release, post-market surveillance, and eventual retirement. The practical risk is not just exploitable code. It is also undocumented change, missing provenance, and a weak link between the SBOM and the records that prove who approved a component for use.
That matters because device teams must be able to explain exposure at the product level, not just at the repository level. A component can be secure at intake and still become unacceptable after a dependency update, a compiler change, or a new vulnerability disclosure. Current guidance from the NIST Cybersecurity Framework 2.0 reinforces the need to govern assets continuously, while regulated manufacturers also need evidence that the lifecycle record is complete enough for audit, complaint handling, and field action decisions. In practice, many security teams encounter governance gaps only after a vulnerability notice or regulatory review has already exposed missing ownership and incomplete change history.
How It Works in Practice
Effective governance starts by treating every open source component as a managed product dependency with a lifecycle record. That record should capture where the component came from, why it was approved, what version was evaluated, what security issues were accepted, and when it must be reviewed again. For medical device teams, this is not just software hygiene. It is part of configuration management, traceability, and quality evidence.
A practical model is to connect the SBOM to release gates and post-release monitoring. The SBOM should not sit as a static document. It should reflect the exact shipped build and link to the approvals that allowed it into a device release. If a library has a known vulnerability, the response path should show whether the issue is mitigated, monitored, remediated, or formally risk accepted. That decision should be tied to the affected product version and the responsible owner.
- Assign a clear owner for each component or dependency chain.
- Track provenance, version, and approval history alongside the build record.
- Define retirement criteria for unsupported libraries and abandoned projects.
- Link vulnerability intake to triage, patching, and documented risk acceptance.
- Preserve evidence for release, verification, and post-market change review.
For control mapping, the NIST SP 800-53 Rev 5 Security and Privacy Controls is useful for translating governance into concrete practices such as configuration management, system integrity, and auditability. Where open source packages are delivered through automated pipelines, teams should also consider whether non-human identities are being used to fetch, sign, scan, or deploy components, because those identities need their own access and secret governance. The OWASP Non-Human Identity Top 10 is relevant where build systems, signing services, or CI/CD bots can indirectly change what ends up in the device. These controls tend to break down when multiple product lines share dependencies but maintain separate release and risk records, because no one can reconstruct which decision applied to which shipped version.
Common Variations and Edge Cases
Tighter component governance often increases engineering and quality overhead, requiring organisations to balance traceability against delivery speed. That tradeoff is real in medical devices, where long support horizons, validated builds, and supplier constraints can make rapid dependency replacement impractical.
Some open source components are low risk in one context and unacceptable in another. A parsing library in a back-office service may tolerate faster patching, while the same library inside safety-relevant device software may require formal revalidation before any update. Current guidance suggests that there is no universal standard for component criticality scoring yet, so teams should use a risk-based method that accounts for attack surface, safety impact, connectivity, and update feasibility.
Edge cases also arise when a project is abandoned upstream, when a package is transitive rather than direct, or when a vulnerability is present but not exploitable in the deployed configuration. In those cases, the governance question is not only whether to patch. It is whether the record clearly explains why the component remains acceptable, what compensating controls exist, and when the decision must be revisited. That distinction is especially important for legacy devices, offline environments, and products with fielded versions that cannot easily be revalidated. For regulated lifecycles, governance should therefore be documented as an operational control, not as a one-time procurement check.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST CSF 2.0 and NIST SP 800-53 Rev 5 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | GV.OC-03 | Open source governance needs clear ownership and lifecycle accountability. |
| NIST SP 800-53 Rev 5 | CM-8 | SBOM-backed inventories support complete configuration management of device software. |
Maintain an accurate component inventory and link each item to shipped builds and approvals.
Related resources from NHI Mgmt Group
- How should security teams govern device-bound payment credentials in open finance?
- How should security teams govern vendor access across the third-party lifecycle?
- How should security teams govern vendor access across the full lifecycle?
- How should teams govern asset lifecycle workflows across users and devices?
